Long Noncoding RNAs in Cancer and Therapeutic Potential.
Details
Serval ID
serval:BIB_A94A89BA2542
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Long Noncoding RNAs in Cancer and Therapeutic Potential.
Journal
Advances in Experimental Medicine and Biology
ISBN
9789811052026
9789811052033
9789811052033
ISSN
0065-2598 (Print)
ISSN-L
0065-2598
Publication state
Published
Issued date
2017
Peer-reviewed
Oui
Volume
1008
Pages
199-222
Language
english
Abstract
Long noncoding RNAs (lncRNAs) are the major elements of the mammalian transcriptome that is emerging as a central player controlling diverse cellular mechanisms. Most of the well-studied lncRNAs so far are found to be crucial in regulating cellular processes such as cell cycle, growth, and apoptosis that ensure homeostasis. Owing to their location and distribution in the genome, lncRNAs influence the transcription of a wide range of proteins directly or indirectly by transcriptional and posttranscriptional alterations, which opens up the "LncRNA-cancer paradigm" in a context-dependent manner, i.e., either oncogenic or tumor suppressive. Thus, this chapter is a consolidation of lncRNA association in exhibiting or suppressing the typical cancer hallmarks such as continuous proliferation, surpassing apoptosis, genomic instability, drug resistance, invasion, and metastasis studied till date. In addition, special focus has been given on the efficient application of lncRNAs as potential targets for therapeutics that holds a great promise for future cancer therapy.
Keywords
Animals, Apoptosis, Cell Cycle, Drug Resistance, Neoplasm/genetics, Genomic Instability, Humans, Neoplasm Invasiveness, Neoplasm Proteins/biosynthesis, Neoplasm Proteins/genetics, Neoplasms/genetics, Neoplasms/metabolism, Neoplasms/pathology, RNA, Long Noncoding/genetics, RNA, Long Noncoding/metabolism, RNA, Neoplasm/genetics, RNA, Neoplasm/metabolism, Transcription, Genetic, Antisense oligonucleotides, Cancer, Chemoresistance, Epigenetic regulation, Gene regulation, Natural antisense transcripts, Therapeutic target, ceRNA
Pubmed
Create date
01/01/2018 16:09
Last modification date
17/09/2020 8:17